Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FSGY7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on December 3, 2025, with an ultimate completion date of December 24, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will perform the work at its Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products to Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR and valued at $499,999,999, was awarded to DMS Pharmaceutical Group on November 13, 2025, and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The contractor supplies a comprehensive range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, and specialty medical consumables to support recurring medical supply needs across the military healthcare system globally. No subcontractors have been identified on this award.
Quick answers
Who was awarded contract SPE2DR26FSGY7?
SPE2DR26FSGY7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FSGY7 worth?
The government has obligated $16,584 on SPE2DR26FSGY7.
Is contract SPE2DR26FSGY7 an order under another contract?
Yes. SPE2DR26FSGY7 is a delivery order under SPE2DR25D9305, an indefinite delivery contract.
Was contract SPE2DR26FSGY7 competed?
The extent of competition for SPE2DR26FSGY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award